Research programme: asthma therapy - PLIVAAlternative Names: Asthma therapy research programme - PLIVA; PLR 8
Latest Information Update: 16 Aug 2007
Price : $50 *
At a glance
- Originator PLIVA d.d.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 05 May 2006 Discontinued - Preclinical for Asthma in Croatia (Inhalation)
- 26 May 2005 Preclinical trials in Asthma in Croatia (Inhalation)